Market revenue in 2023 | USD 18.9 million |
Market revenue in 2030 | USD 31.5 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Transbronchial needle aspiration (tbna) needles |
Fastest growing segment | Transbronchial Needle Aspiration (TBNA) Needles |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopsy Forceps, Transbronchial Needle Aspiration (TBNA) Needles, Cytology Brushes |
Key market players worldwide | Olympus Corp, Boston Scientific Corp, Conmed Corp, Medtronic PLC, Becton Dickinson & Co, Hobbs Medical, Cook Medical, Telemed Systems, Argon Medical Devices, Horizons International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchial biopsy devices market will help companies and investors design strategic landscapes.
Transbronchial needle aspiration (tbna) needles was the largest segment with a revenue share of 65.08% in 2023. Horizon Databook has segmented the Australia bronchial biopsy devices market based on biopsy forceps, transbronchial needle aspiration (tbna) needles, cytology brushes covering the revenue growth of each sub-segment from 2018 to 2030.
Australia is recognized for its advanced healthcare system, bolstered by the public and private sectors. The government’s emphasis on enhancing healthcare delivery and integrating technology is expected to drive the development and adoption of advanced diagnostic tools, including bronchial biopsy devices.
In Australia, the adoption of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) is increasingly recognized for its effectiveness in diagnosing lung cancer and other respiratory conditions. This minimally invasive technique allows for the sampling of mediastinal lymph nodes, providing critical information for staging lung cancer and evaluating other thoracic diseases.
A notable study conducted across 4 Australian tertiary referral centers highlighted the utility of EBUS-TBNA in diagnosing mediastinal tuberculous lymphadenitis. The study demonstrated that EBUS-TBNA is effective and has a high diagnostic accuracy for various conditions, including lung cancer.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia bronchial biopsy devices market , including forecasts for subscribers. This country databook contains high-level insights into Australia bronchial biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account